Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_assertion type Assertion NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_head.
- NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_assertion description "[dc-CISH is a promising alternative to FISH in HER2 testing, and the single-institute incidence of HER2 amplification in breast cancer in Taiwan is 21.2%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_provenance.
- NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_assertion evidence source_evidence_literature NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_provenance.
- NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_assertion SIO_000772 22092410 NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_provenance.
- NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_assertion wasDerivedFrom befree-2016 NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_provenance.
- NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_assertion wasGeneratedBy ECO_0000203 NP939435.RASVD72IHShS_socjxO67CYIgJVX8RGq6-jWIaGpeArSA130_provenance.